Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Lymphoid 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 34Lung Neoplasms 23Carcinoma, Non-Small-Cell Lung 18Neoplasms 15Uterine Cervical Neoplasms 9Esophageal Neoplasms 9Brain Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Solid Tumor 7Rectal Neoplasms 7Lymphoma 7Glioblastoma 7Carcinoma, Hepatocellular 7Prostatic Neoplasms 6Pancreatic Neoplasms 6Neoplasm Metastasis 6Multiple Myeloma 6Melanoma 6Hodgkin Disease 6Colorectal Neoplasms 6Colonic Neoplasms 6Carcinoma, Renal Cell 6Breast Neoplasms, Male 6Stomach Neoplasms 5Sarcoma 5Neuroendocrine Tumors 5Lymphoma, Large B-Cell, Diffuse 5Carcinoma, Transitional Cell 5Thyroid Neoplasms 4Ovarian Neoplasms 4

Interventions

Carboplatin 88pembrolizumab 85Paclitaxel 71Cyclophosphamide 63Capecitabine 38Doxorubicin 37Taxes 29130-nm albumin-bound paclitaxel 29Cisplatin 25Albumin-Bound Paclitaxel 22Epirubicin 21Drug Therapy 21Docetaxel 20sacituzumab govitecan 19olaparib 19camrelizumab 18atezolizumab 18Gemcitabine 17eribulin 16durvalumab 16Bevacizumab 16Radiotherapy 15toripalimab 14Specimen Handling 14Biopsy 13Everolimus 12Magnetic Resonance Spectroscopy 11apatinib 10Nivolumab 10talazoparib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Triple Negative Breast Neoplasms × Fluorodeoxyglucose F18 × Clear all
NCT02599194 2019-01-03

18F-FSPG PET/CT for Cancer Patients on Therapy

Stanford University

Phase 2 Completed
7 enrolled 6 charts
BreastGenitourinaryLymphoidOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Lymphoma, B-Cell, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡